Global Medical Simulation Market Overview

The Global Medical Simulation Market size is expected to grow from USD 3.27 Billion in 2023 to USD 12.43 Billion by 2032, at a CAGR of 15.99% during the forecast period (2024-2032)

The role of telematics and virtual simulations as a constructive educational method for both technical and non-technical skill have been already demonstrated throughout the years in several educational methods. Medical simulation in the healthcare system builds a safe learning environment, for practitioners and researchers to test new clinical processes and improve their teams' and individuals' skills. Most of the simulation methods are comprised of artificial patients, that display symptom, and also respond to the simulated treatment. This enables specialists to upgrade their clinical skills without risking patient lives. Additionally, a trainee can make mistakes and then learn from them without putting patients' lives at risk. Medical simulation techniques are utilized by academic institutes, hospitals, military organizations, and researchers. The growing number of healthcare professionals has escalated the demand for hands-on patient techniques. According to the article Medical Error Reduction and Prevention, medical errors cost approximately US$ 20 billion each year and roughly 100,000 people die due to medical errors in hospitals and clinics. Thus, to prevent medical errors, medical simulation procedures can be extensively utilized thereby, strengthening the expansion of the market over the projected period.

Market Dynamics and Key Factors in Medical Simulation Market:

Drivers:

The technological advancement in Virtual Reality and Augmented Reality platforms has created new methods to deliver health education while promoting safety. Medical simulation creates educational opportunities for multiple healthcare professionals to come together and improve the quality of patient care. It also helps in developing teamwork in a situation like medical crises, based on principles of structured communication, effective assertion, active information sharing, and a shared understanding of psychological safety, situational awareness, and effective leadership behaviors. Medical simulation provides scheduled, valuable learning experiences that cannot be achieved through traditional teaching methods. Medical simulation enhances learners' qualities such as hands-on and thinking skills, including knowledge-in-action, procedures, decision-making, and effective communication.

Moreover, critical teamwork behaviors such as managing high workload, trapping errors, and coordinating under stress can be taught and practiced through medical simulation methods. Training covers everything from preventive care to invasive surgery. Many clinical situations can be simulated at will, these learning opportunities can be planned at convenient times and locations and can be repeated as needed. Medical simulation techniques can be utilized to help distant students in performing surgeries and other processes together. Medical simulation is a well-known application to train and prepare healthcare workers for difficult and hazardous scenarios. In particular, simulation enhances healthcare workers' skills and can be utilized to validate protocols, identify threats and issues, and test solutions thus, helping the expansion of the medical simulation market during the analysis period.

Restraints:

The lack of dedicated simulation operations specialists (SimOps) is the major factor hindering the expansion of the medical simulation market in some regions. Moreover, most of the simulators utilized currently are expensive and require regular updates of the software. In developing regions, the medical simulation centers rely heavily on government and private fundings. Recently due to economic crises in some countries, the fundings for medical simulators have been diverted thus, the expansion of the medical simulator market in these countries is restricted.

Opportunities:

Faculty are beginning to get trained in simulators and are consequently understanding their importance, especially for patient safety and teaching diverse behavioral skills. Recently there has been an unprecedented rise in the adoption of medical simulators in developed economies and the developing countries are following their lead. Simulation societies are now actively educating teaching faculty across healthcare disciplines through faculty development programs and conferences. Furthermore, the growing concern of medical errors has promoted all the end-users to adopt medical simulators to reduce the cost generated due to medical errors and prevent people from dying thus, creating a profitable opportunity for the market players involved in the medical simulation market.

Market Segmentation

Depending on products and services, the healthcare anatomical models' segment is expected to dominate the medical simulation market during the projected period. Anatomical models help surgeons to plan and practice for operations. Cardiac and brain surgeries have been a vital challenge for surgeons owing to the complex nature of these surgeries and the need for highly skilled professionals thus, anatomical models can be utilized to promote patient safety in these complex operative procedures. Healthcare anatomical models can be used to simulate ultrasound, dental, endovascular, and eye operations and to teach common individuals about CPR techniques thus, supporting the growth of healthcare anatomical models' segment.

Depending on end-users, the academic institute's segment is forecasted to lead the medical simulation market over the forecast period. The increased awareness about patient safety and to produce the best healthcare professionals is stimulating academic institutes to adopt medical simulation methods. Moreover, to support the development of academic institutes there has been an increase in fundings from the government as well as from private entities. Academic institutes play a vital role in elevating the standard of learning thus, strengthening segments' growth.

Depending on fidelity, the high-fidelity segment is anticipated to have the highest CAGR in the analysis period. The high-fidelity simulation used in healthcare education methodology involves the usage of sophisticated life-like manikins in realistic patient environments. These high-fidelity simulators are similar to human anatomy and physiology. High-fidelity manikins can perform functions characterized by humans such as expanding chests to breathe, palpable pulses, variable heart rates and tones, and measurable blood pressure. Procedures such as bag-mask ventilation, intubation, defibrillation, chest tube placement, cricothyrotomy, and others can be performed on the manikins. Some high-fidelity simulators are specifically designed to portray clinical situations such as trauma manikins with severely damaged or missing limbs, newborn or premature babies, birthing manikins that mimic a woman during labor, and delivery and smaller pediatric manikins. High-fidelity manikins create more realistic clinical scenarios and thus help in enhancing the skills of learners thereby, fueling the growth of the high-fidelity segment. 

Players Covered in Medical Simulation market are :

• 3D Systems (US)
• CAE (Canada)
• 3B Scientific (Germany)
• Gaumard Scientific Company (US)
• Kyoto Kagaku (Japan)
• Laerdal Medical (Norway)
• Limbs & Things (UK)
• IP Group plc (UK)
• Mentice AB (US)
• Operative Experience Inc. (US)
• Simulab Corporation (US)
• Simulaids (UK)
• SynBone AG (Switzerland)
• VirtaMed AG (Switzerland)
• VRMagic Holding AG (Germany)
• Surgical Science (Sweden) and other major players.

Regional Analysis of Medical Simulation Market:

The North American region is forecasted to have the highest share of the medical simulation market in the forecast period attributed to the presence of prominent service providers and the high adoption rate of emerging technologies. Moreover, to enhance patient safety, medical simulation is widely utilized by institutes and hospitals to raise the standard of teaching methods. The supportive government stands such as the USA simulation program which aims at delivering high-quality, realistic simulated clinical learning experiences for health/medical professions students and clinicians, to prepare them for an advancing healthcare system, is consolidating the expansion of the medical simulation market in this region.

The European region is anticipated to have the second-highest share of the medical simulation market during the projected period owing to the rapid technological advancements in the healthcare system, and the growing popularity of virtual and online training amid the COVID-19 pandemic. The academic institutes in this region are focused on preparing students and clinicians to provide the highest levels of healthcare facilities across populations and communities, thus, there has been a significant rise in the usage of simulation methods in the healthcare sector.

The Asia-Pacific region is expected to develop at the highest CAGR over the analysis period. The growing inclination towards simulation techniques to improve healthcare facilities and the increasing demand of healthcare professionals for hands-on patient training are the main factors supporting the development of the medical simulation market in this region. Recently, there has been an upsurge in the number of centers offering medical simulation services, and healthcare fundings. The strategic collaborations and agreements between companies are enhancing the technologies utilized in the medical simulation thus, strengthening the development of the market in this region.

Recent Industry Developments in Medical Simulation Market:

• In January 2024, GigXR Inc., a global provider of extended reality (XR) solutions for healthcare training, and CAE Healthcare announced their partnership to enhance the efficiency and effectiveness of clinical simulation. The collaboration between GigXR and CAE Healthcare streamlines the ability to implement and manage multimodal simulation for medical schools, nursing schools, hospital systems, first responders, and government – spanning analog, immersive, and digital modalities that can be used to create full curricula.
• In August 2023, 3B Scientific, a leading manufacturer and marketer of medical simulation products and anatomical models for healthcare education, announced that it has reached an agreement to acquire Lifecast Body Simulation.

Chapter 1: Introduction
 1.1 Research Objectives
 1.2 Research Methodology
 1.3 Research Process
 1.4 Scope and Coverage
  1.4.1 Market Definition
  1.4.2 Key Questions Answered
 1.5 Market Segmentation

Chapter 2:Executive Summary

Chapter 3:Growth Opportunities By Segment
 3.1 By Fidelity
 3.2 By Type
 3.3 By End-User

Chapter 4: Market Landscape
 4.1 Porter's Five Forces Analysis
  4.1.1 Bargaining Power of Supplier
  4.1.2 Threat of New Entrants
  4.1.3 Threat of Substitutes
  4.1.4 Competitive Rivalry
  4.1.5 Bargaining Power Among Buyers
 4.2 Industry Value Chain Analysis
 4.3 Market Dynamics
  4.3.1 Drivers
  4.3.2 Restraints
  4.3.3 Opportunities
  4.5.4 Challenges
 4.4 Pestle Analysis
 4.5 Technological Roadmap
 4.6 Regulatory Landscape
 4.7 SWOT Analysis
 4.8 Price Trend Analysis
 4.9 Patent Analysis
 4.10 Analysis of the Impact of Covid-19
  4.10.1 Impact on the Overall Market
  4.10.2 Impact on the Supply Chain
  4.10.3 Impact on the Key Manufacturers
  4.10.4 Impact on the Pricing

Chapter 5: Medical Simulation Market by Fidelity
 5.1 Medical Simulation Market Overview Snapshot and Growth Engine
 5.2 Medical Simulation Market Overview
 5.3 Low
  5.3.1 Introduction and Market Overview
  5.3.2 Historic and Forecasted Market Size (2016-2028F)
  5.3.3 Key Market Trends, Growth Factors and Opportunities
  5.3.4 Low: Grographic Segmentation
 5.4 Medium
  5.4.1 Introduction and Market Overview
  5.4.2 Historic and Forecasted Market Size (2016-2028F)
  5.4.3 Key Market Trends, Growth Factors and Opportunities
  5.4.4 Medium: Grographic Segmentation
 5.5 High
  5.5.1 Introduction and Market Overview
  5.5.2 Historic and Forecasted Market Size (2016-2028F)
  5.5.3 Key Market Trends, Growth Factors and Opportunities
  5.5.4 High: Grographic Segmentation

Chapter 6: Medical Simulation Market by Type
 6.1 Medical Simulation Market Overview Snapshot and Growth Engine
 6.2 Medical Simulation Market Overview
 6.3 Healthcare Anatomical Models
  6.3.1 Introduction and Market Overview
  6.3.2 Historic and Forecasted Market Size (2016-2028F)
  6.3.3 Key Market Trends, Growth Factors and Opportunities
  6.3.4 Healthcare Anatomical Models: Grographic Segmentation
 6.4 Web-Based Simulators
  6.4.1 Introduction and Market Overview
  6.4.2 Historic and Forecasted Market Size (2016-2028F)
  6.4.3 Key Market Trends, Growth Factors and Opportunities
  6.4.4 Web-Based Simulators: Grographic Segmentation
 6.5 Healthcare Simulation Software
  6.5.1 Introduction and Market Overview
  6.5.2 Historic and Forecasted Market Size (2016-2028F)
  6.5.3 Key Market Trends, Growth Factors and Opportunities
  6.5.4 Healthcare Simulation Software: Grographic Segmentation
 6.6 Simulation Training Services
  6.6.1 Introduction and Market Overview
  6.6.2 Historic and Forecasted Market Size (2016-2028F)
  6.6.3 Key Market Trends, Growth Factors and Opportunities
  6.6.4 Simulation Training Services: Grographic Segmentation

Chapter 7: Medical Simulation Market by End-User
 7.1 Medical Simulation Market Overview Snapshot and Growth Engine
 7.2 Medical Simulation Market Overview
 7.3 Academic Institutes
  7.3.1 Introduction and Market Overview
  7.3.2 Historic and Forecasted Market Size (2016-2028F)
  7.3.3 Key Market Trends, Growth Factors and Opportunities
  7.3.4 Academic Institutes: Grographic Segmentation
 7.4 Hospitals
  7.4.1 Introduction and Market Overview
  7.4.2 Historic and Forecasted Market Size (2016-2028F)
  7.4.3 Key Market Trends, Growth Factors and Opportunities
  7.4.4 Hospitals: Grographic Segmentation
 7.5 Military Organization
  7.5.1 Introduction and Market Overview
  7.5.2 Historic and Forecasted Market Size (2016-2028F)
  7.5.3 Key Market Trends, Growth Factors and Opportunities
  7.5.4 Military Organization: Grographic Segmentation
 7.6 Research
  7.6.1 Introduction and Market Overview
  7.6.2 Historic and Forecasted Market Size (2016-2028F)
  7.6.3 Key Market Trends, Growth Factors and Opportunities
  7.6.4 Research: Grographic Segmentation
 7.7 Others
  7.7.1 Introduction and Market Overview
  7.7.2 Historic and Forecasted Market Size (2016-2028F)
  7.7.3 Key Market Trends, Growth Factors and Opportunities
  7.7.4 Others: Grographic Segmentation

Chapter 8: Company Profiles and Competitive Analysis
 8.1 Competitive Landscape
  8.1.1 Competitive Positioning
  8.1.2 Medical Simulation Sales and Market Share By Players
  8.1.3 Industry BCG Matrix
  8.1.4 Ansoff Matrix
  8.1.5 Medical Simulation Industry Concentration Ratio (CR5 and HHI)
  8.1.6 Top 5 Medical Simulation Players Market Share
  8.1.7 Mergers and Acquisitions
  8.1.8 Business Strategies By Top Players
 8.2 3D SYSTEMS
  8.2.1 Company Overview
  8.2.2 Key Executives
  8.2.3 Company Snapshot
  8.2.4 Operating Business Segments
  8.2.5 Product Portfolio
  8.2.6 Business Performance
  8.2.7 Key Strategic Moves and Recent Developments
  8.2.8 SWOT Analysis
 8.3 CAE
 8.4 3B SCIENTIFIC
 8.5 GAUMARD SCIENTIFIC COMPANY
 8.6 KYOTO KAGAKU
 8.7 LAERDAL MEDICAL
 8.8 LIMBS & THINGS
 8.9 IP GROUP PLC
 8.10 MENTICE AB
 8.11 OPERATIVE EXPERIENCE INC.
 8.12 SIMULAB CORPORATION
 8.13 SIMULAIDS
 8.14 SYNBONE AG
 8.15 VIRTAMED AG
 8.16 VRMAGIC HOLDING AG
 8.17 SURGICAL SCIENCE
 8.18 OTHER MAJOR PLAYERS

Chapter 9: Global Medical Simulation Market Analysis, Insights and Forecast, 2016-2028
 9.1 Market Overview
 9.2 Historic and Forecasted Market Size By Fidelity
  9.2.1 Low
  9.2.2 Medium
  9.2.3 High
 9.3 Historic and Forecasted Market Size By Type
  9.3.1 Healthcare Anatomical Models
  9.3.2 Web-Based Simulators
  9.3.3 Healthcare Simulation Software
  9.3.4 Simulation Training Services
 9.4 Historic and Forecasted Market Size By End-User
  9.4.1 Academic Institutes
  9.4.2 Hospitals
  9.4.3 Military Organization
  9.4.4 Research
  9.4.5 Others

Chapter 10: North America Medical Simulation Market Analysis, Insights and Forecast, 2016-2028
 10.1 Key Market Trends, Growth Factors and Opportunities
 10.2 Impact of Covid-19
 10.3 Key Players
 10.4 Key Market Trends, Growth Factors and Opportunities
 10.4 Historic and Forecasted Market Size By Fidelity
  10.4.1 Low
  10.4.2 Medium
  10.4.3 High
 10.5 Historic and Forecasted Market Size By Type
  10.5.1 Healthcare Anatomical Models
  10.5.2 Web-Based Simulators
  10.5.3 Healthcare Simulation Software
  10.5.4 Simulation Training Services
 10.6 Historic and Forecasted Market Size By End-User
  10.6.1 Academic Institutes
  10.6.2 Hospitals
  10.6.3 Military Organization
  10.6.4 Research
  10.6.5 Others
 10.7 Historic and Forecast Market Size by Country
  10.7.1 U.S.
  10.7.2 Canada
  10.7.3 Mexico

Chapter 11: Europe Medical Simulation Market Analysis, Insights and Forecast, 2016-2028
 11.1 Key Market Trends, Growth Factors and Opportunities
 11.2 Impact of Covid-19
 11.3 Key Players
 11.4 Key Market Trends, Growth Factors and Opportunities
 11.4 Historic and Forecasted Market Size By Fidelity
  11.4.1 Low
  11.4.2 Medium
  11.4.3 High
 11.5 Historic and Forecasted Market Size By Type
  11.5.1 Healthcare Anatomical Models
  11.5.2 Web-Based Simulators
  11.5.3 Healthcare Simulation Software
  11.5.4 Simulation Training Services
 11.6 Historic and Forecasted Market Size By End-User
  11.6.1 Academic Institutes
  11.6.2 Hospitals
  11.6.3 Military Organization
  11.6.4 Research
  11.6.5 Others
 11.7 Historic and Forecast Market Size by Country
  11.7.1 Germany
  11.7.2 U.K.
  11.7.3 France
  11.7.4 Italy
  11.7.5 Russia
  11.7.6 Spain
  11.7.7 Rest of Europe

Chapter 12: Asia-Pacific Medical Simulation Market Analysis, Insights and Forecast, 2016-2028
 12.1 Key Market Trends, Growth Factors and Opportunities
 12.2 Impact of Covid-19
 12.3 Key Players
 12.4 Key Market Trends, Growth Factors and Opportunities
 12.4 Historic and Forecasted Market Size By Fidelity
  12.4.1 Low
  12.4.2 Medium
  12.4.3 High
 12.5 Historic and Forecasted Market Size By Type
  12.5.1 Healthcare Anatomical Models
  12.5.2 Web-Based Simulators
  12.5.3 Healthcare Simulation Software
  12.5.4 Simulation Training Services
 12.6 Historic and Forecasted Market Size By End-User
  12.6.1 Academic Institutes
  12.6.2 Hospitals
  12.6.3 Military Organization
  12.6.4 Research
  12.6.5 Others
 12.7 Historic and Forecast Market Size by Country
  12.7.1 China
  12.7.2 India
  12.7.3 Japan
  12.7.4 Singapore
  12.7.5 Australia
  12.7.6 New Zealand
  12.7.7 Rest of APAC

Chapter 13: Middle East & Africa Medical Simulation Market Analysis, Insights and Forecast, 2016-2028
 13.1 Key Market Trends, Growth Factors and Opportunities
 13.2 Impact of Covid-19
 13.3 Key Players
 13.4 Key Market Trends, Growth Factors and Opportunities
 13.4 Historic and Forecasted Market Size By Fidelity
  13.4.1 Low
  13.4.2 Medium
  13.4.3 High
 13.5 Historic and Forecasted Market Size By Type
  13.5.1 Healthcare Anatomical Models
  13.5.2 Web-Based Simulators
  13.5.3 Healthcare Simulation Software
  13.5.4 Simulation Training Services
 13.6 Historic and Forecasted Market Size By End-User
  13.6.1 Academic Institutes
  13.6.2 Hospitals
  13.6.3 Military Organization
  13.6.4 Research
  13.6.5 Others
 13.7 Historic and Forecast Market Size by Country
  13.7.1 Turkey
  13.7.2 Saudi Arabia
  13.7.3 Iran
  13.7.4 UAE
  13.7.5 Africa
  13.7.6 Rest of MEA

Chapter 14: South America Medical Simulation Market Analysis, Insights and Forecast, 2016-2028
 14.1 Key Market Trends, Growth Factors and Opportunities
 14.2 Impact of Covid-19
 14.3 Key Players
 14.4 Key Market Trends, Growth Factors and Opportunities
 14.4 Historic and Forecasted Market Size By Fidelity
  14.4.1 Low
  14.4.2 Medium
  14.4.3 High
 14.5 Historic and Forecasted Market Size By Type
  14.5.1 Healthcare Anatomical Models
  14.5.2 Web-Based Simulators
  14.5.3 Healthcare Simulation Software
  14.5.4 Simulation Training Services
 14.6 Historic and Forecasted Market Size By End-User
  14.6.1 Academic Institutes
  14.6.2 Hospitals
  14.6.3 Military Organization
  14.6.4 Research
  14.6.5 Others
 14.7 Historic and Forecast Market Size by Country
  14.7.1 Brazil
  14.7.2 Argentina
  14.7.3 Rest of SA

Chapter 15 Investment Analysis

Chapter 16 Analyst Viewpoint and Conclusion

LIST OF TABLES

TABLE 001. EXECUTIVE SUMMARY
TABLE 002. MEDICAL SIMULATION MARKET BARGAINING POWER OF SUPPLIERS
TABLE 003. MEDICAL SIMULATION MARKET BARGAINING POWER OF CUSTOMERS
TABLE 004. MEDICAL SIMULATION MARKET COMPETITIVE RIVALRY
TABLE 005. MEDICAL SIMULATION MARKET THREAT OF NEW ENTRANTS
TABLE 006. MEDICAL SIMULATION MARKET THREAT OF SUBSTITUTES
TABLE 007. MEDICAL SIMULATION MARKET BY FIDELITY
TABLE 008. LOW MARKET OVERVIEW (2016-2028)
TABLE 009. MEDIUM MARKET OVERVIEW (2016-2028)
TABLE 010. HIGH MARKET OVERVIEW (2016-2028)
TABLE 011. MEDICAL SIMULATION MARKET BY TYPE
TABLE 012. HEALTHCARE ANATOMICAL MODELS MARKET OVERVIEW (2016-2028)
TABLE 013. WEB-BASED SIMULATORS MARKET OVERVIEW (2016-2028)
TABLE 014. HEALTHCARE SIMULATION SOFTWARE MARKET OVERVIEW (2016-2028)
TABLE 015. SIMULATION TRAINING SERVICES MARKET OVERVIEW (2016-2028)
TABLE 016. MEDICAL SIMULATION MARKET BY END-USER
TABLE 017. ACADEMIC INSTITUTES MARKET OVERVIEW (2016-2028)
TABLE 018. HOSPITALS MARKET OVERVIEW (2016-2028)
TABLE 019. MILITARY ORGANIZATION MARKET OVERVIEW (2016-2028)
TABLE 020. RESEARCH MARKET OVERVIEW (2016-2028)
TABLE 021. OTHERS MARKET OVERVIEW (2016-2028)
TABLE 022. NORTH AMERICA MEDICAL SIMULATION MARKET, BY FIDELITY (2016-2028)
TABLE 023. NORTH AMERICA MEDICAL SIMULATION MARKET, BY TYPE (2016-2028)
TABLE 024. NORTH AMERICA MEDICAL SIMULATION MARKET, BY END-USER (2016-2028)
TABLE 025. N MEDICAL SIMULATION MARKET, BY COUNTRY (2016-2028)
TABLE 026. EUROPE MEDICAL SIMULATION MARKET, BY FIDELITY (2016-2028)
TABLE 027. EUROPE MEDICAL SIMULATION MARKET, BY TYPE (2016-2028)
TABLE 028. EUROPE MEDICAL SIMULATION MARKET, BY END-USER (2016-2028)
TABLE 029. MEDICAL SIMULATION MARKET, BY COUNTRY (2016-2028)
TABLE 030. ASIA PACIFIC MEDICAL SIMULATION MARKET, BY FIDELITY (2016-2028)
TABLE 031. ASIA PACIFIC MEDICAL SIMULATION MARKET, BY TYPE (2016-2028)
TABLE 032. ASIA PACIFIC MEDICAL SIMULATION MARKET, BY END-USER (2016-2028)
TABLE 033. MEDICAL SIMULATION MARKET, BY COUNTRY (2016-2028)
TABLE 034. MIDDLE EAST & AFRICA MEDICAL SIMULATION MARKET, BY FIDELITY (2016-2028)
TABLE 035. MIDDLE EAST & AFRICA MEDICAL SIMULATION MARKET, BY TYPE (2016-2028)
TABLE 036. MIDDLE EAST & AFRICA MEDICAL SIMULATION MARKET, BY END-USER (2016-2028)
TABLE 037. MEDICAL SIMULATION MARKET, BY COUNTRY (2016-2028)
TABLE 038. SOUTH AMERICA MEDICAL SIMULATION MARKET, BY FIDELITY (2016-2028)
TABLE 039. SOUTH AMERICA MEDICAL SIMULATION MARKET, BY TYPE (2016-2028)
TABLE 040. SOUTH AMERICA MEDICAL SIMULATION MARKET, BY END-USER (2016-2028)
TABLE 041. MEDICAL SIMULATION MARKET, BY COUNTRY (2016-2028)
TABLE 042. 3D SYSTEMS: SNAPSHOT
TABLE 043. 3D SYSTEMS: BUSINESS PERFORMANCE
TABLE 044. 3D SYSTEMS: PRODUCT PORTFOLIO
TABLE 045. 3D SYSTEMS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 045. CAE: SNAPSHOT
TABLE 046. CAE: BUSINESS PERFORMANCE
TABLE 047. CAE: PRODUCT PORTFOLIO
TABLE 048. CAE: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 048. 3B SCIENTIFIC: SNAPSHOT
TABLE 049. 3B SCIENTIFIC: BUSINESS PERFORMANCE
TABLE 050. 3B SCIENTIFIC: PRODUCT PORTFOLIO
TABLE 051. 3B SCIENTIFIC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 051. GAUMARD SCIENTIFIC COMPANY: SNAPSHOT
TABLE 052. GAUMARD SCIENTIFIC COMPANY: BUSINESS PERFORMANCE
TABLE 053. GAUMARD SCIENTIFIC COMPANY: PRODUCT PORTFOLIO
TABLE 054. GAUMARD SCIENTIFIC COMPANY: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 054. KYOTO KAGAKU: SNAPSHOT
TABLE 055. KYOTO KAGAKU: BUSINESS PERFORMANCE
TABLE 056. KYOTO KAGAKU: PRODUCT PORTFOLIO
TABLE 057. KYOTO KAGAKU: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 057. LAERDAL MEDICAL: SNAPSHOT
TABLE 058. LAERDAL MEDICAL: BUSINESS PERFORMANCE
TABLE 059. LAERDAL MEDICAL: PRODUCT PORTFOLIO
TABLE 060. LAERDAL MEDICAL: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 060. LIMBS & THINGS: SNAPSHOT
TABLE 061. LIMBS & THINGS: BUSINESS PERFORMANCE
TABLE 062. LIMBS & THINGS: PRODUCT PORTFOLIO
TABLE 063. LIMBS & THINGS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 063. IP GROUP PLC: SNAPSHOT
TABLE 064. IP GROUP PLC: BUSINESS PERFORMANCE
TABLE 065. IP GROUP PLC: PRODUCT PORTFOLIO
TABLE 066. IP GROUP PLC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 066. MENTICE AB: SNAPSHOT
TABLE 067. MENTICE AB: BUSINESS PERFORMANCE
TABLE 068. MENTICE AB: PRODUCT PORTFOLIO
TABLE 069. MENTICE AB: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 069. OPERATIVE EXPERIENCE INC.: SNAPSHOT
TABLE 070. OPERATIVE EXPERIENCE INC.: BUSINESS PERFORMANCE
TABLE 071. OPERATIVE EXPERIENCE INC.: PRODUCT PORTFOLIO
TABLE 072. OPERATIVE EXPERIENCE INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 072. SIMULAB CORPORATION: SNAPSHOT
TABLE 073. SIMULAB CORPORATION: BUSINESS PERFORMANCE
TABLE 074. SIMULAB CORPORATION: PRODUCT PORTFOLIO
TABLE 075. SIMULAB CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 075. SIMULAIDS: SNAPSHOT
TABLE 076. SIMULAIDS: BUSINESS PERFORMANCE
TABLE 077. SIMULAIDS: PRODUCT PORTFOLIO
TABLE 078. SIMULAIDS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 078. SYNBONE AG: SNAPSHOT
TABLE 079. SYNBONE AG: BUSINESS PERFORMANCE
TABLE 080. SYNBONE AG: PRODUCT PORTFOLIO
TABLE 081. SYNBONE AG: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 081. VIRTAMED AG: SNAPSHOT
TABLE 082. VIRTAMED AG: BUSINESS PERFORMANCE
TABLE 083. VIRTAMED AG: PRODUCT PORTFOLIO
TABLE 084. VIRTAMED AG: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 084. VRMAGIC HOLDING AG: SNAPSHOT
TABLE 085. VRMAGIC HOLDING AG: BUSINESS PERFORMANCE
TABLE 086. VRMAGIC HOLDING AG: PRODUCT PORTFOLIO
TABLE 087. VRMAGIC HOLDING AG: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 087. SURGICAL SCIENCE: SNAPSHOT
TABLE 088. SURGICAL SCIENCE: BUSINESS PERFORMANCE
TABLE 089. SURGICAL SCIENCE: PRODUCT PORTFOLIO
TABLE 090. SURGICAL SCIENCE: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 090. OTHER MAJOR PLAYERS: SNAPSHOT
TABLE 091. OTHER MAJOR PLAYERS: BUSINESS PERFORMANCE
TABLE 092. OTHER MAJOR PLAYERS: PRODUCT PORTFOLIO
TABLE 093. OTHER MAJOR PLAYERS: KEY STRATEGIC MOVES AND DEVELOPMENTS

LIST OF FIGURES

FIGURE 001. YEARS CONSIDERED FOR ANALYSIS
FIGURE 002. SCOPE OF THE STUDY
FIGURE 003. MEDICAL SIMULATION MARKET OVERVIEW BY REGIONS
FIGURE 004. PORTER'S FIVE FORCES ANALYSIS
FIGURE 005. BARGAINING POWER OF SUPPLIERS
FIGURE 006. COMPETITIVE RIVALRYFIGURE 007. THREAT OF NEW ENTRANTS
FIGURE 008. THREAT OF SUBSTITUTES
FIGURE 009. VALUE CHAIN ANALYSIS
FIGURE 010. PESTLE ANALYSIS
FIGURE 011. MEDICAL SIMULATION MARKET OVERVIEW BY FIDELITY
FIGURE 012. LOW MARKET OVERVIEW (2016-2028)
FIGURE 013. MEDIUM MARKET OVERVIEW (2016-2028)
FIGURE 014. HIGH MARKET OVERVIEW (2016-2028)
FIGURE 015. MEDICAL SIMULATION MARKET OVERVIEW BY TYPE
FIGURE 016. HEALTHCARE ANATOMICAL MODELS MARKET OVERVIEW (2016-2028)
FIGURE 017. WEB-BASED SIMULATORS MARKET OVERVIEW (2016-2028)
FIGURE 018. HEALTHCARE SIMULATION SOFTWARE MARKET OVERVIEW (2016-2028)
FIGURE 019. SIMULATION TRAINING SERVICES MARKET OVERVIEW (2016-2028)
FIGURE 020. MEDICAL SIMULATION MARKET OVERVIEW BY END-USER
FIGURE 021. ACADEMIC INSTITUTES MARKET OVERVIEW (2016-2028)
FIGURE 022. HOSPITALS MARKET OVERVIEW (2016-2028)
FIGURE 023. MILITARY ORGANIZATION MARKET OVERVIEW (2016-2028)
FIGURE 024. RESEARCH MARKET OVERVIEW (2016-2028)
FIGURE 025. OTHERS MARKET OVERVIEW (2016-2028)
FIGURE 026. NORTH AMERICA MEDICAL SIMULATION MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 027. EUROPE MEDICAL SIMULATION MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 028. ASIA PACIFIC MEDICAL SIMULATION MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 029. MIDDLE EAST & AFRICA MEDICAL SIMULATION MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 030. SOUTH AMERICA MEDICAL SIMULATION MARKET OVERVIEW BY COUNTRY (2016-2028)